tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports
Want to see KLRS full AI Analyst Report?

Kalaris Therapeutics (KLRS) Income Statement

375 Followers

Kalaris Therapeutics Income Statement

Last quarter (Q4 2025), Kalaris Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kalaris Therapeutics's net income was $-10.00M. See Kalaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -13.00K$ 0.00$ 0.00$ 0.00$ -1.12M
Operating Expenses
$ 46.14M$ 55.26M$ 13.46M$ 14.01M$ 168.70M
Depreciation and Amortization
$ 13.00K$ 0.00$ 0.00$ 0.00$ 1.12M
EBITDA
$ -46.14M$ -58.77M$ -14.01M$ -15.25M$ -169.84M
Operating Income
$ -46.15M$ -55.26M$ -13.46M$ -14.01M$ -169.82M
Other Income/Expenses
$ 2.71M$ -3.51M$ -1.24M$ -1.48M$ -1.14M
Pretax Income
$ -43.44M$ -58.77M$ -14.70M$ -15.48M$ -170.96M
Net Income
$ -43.44M$ -58.77M$ -14.70M$ -15.48M$ -171.96M
Per Share Metrics
Basic EPS
$ -2.85$ -11.73$ -42.09$ -50.62$ -63.00
Diluted EPS
$ -2.85$ -11.73$ -42.09$ -50.62$ -63.00
Weighted Average Shares Outstanding
 15.27M 5.01M 4.52M 3.33M 2.73M
Weighted Average Shares Outstanding (Diluted)
 15.27M 5.01M 4.52M 3.33M 2.73M
Currency in USD

Kalaris Therapeutics Earnings and Revenue History